Opioids
by Jenna Ogilvie | Nov 9, 2020 | Commentary, Perspectives
The opioid epidemic is raging within the COVID-19 pandemic, with more than 40 states reporting increases in opioid-related overdoses and deaths. COVID-19 has disrupted health care services, disproportionately affecting already marginalized populations. Prior to...
by Jenna Ogilvie | Oct 26, 2020 | Discussion Paper, Perspectives
The United States is in the midst of an unprecedented crisis of prescription and illicit opioid misuse, use disorder, and overdose. In 2018, nearly 47,000 Americans died from an overdose involving opioids [174]. In 2018, 10.3 million people aged 12 years...
by Jenna Ogilvie | Aug 10, 2020 | Discussion Paper, Perspectives
Introduction Ensuring high-quality, respectful, and appropriate management of chronic non-cancer pain (CNCP) in the context of the US opioid crisis is a critical and complex endeavor. At the end of the twentieth century, opioids became the standard...
by Jenna Ogilvie | Apr 27, 2020 | Discussion Paper, Perspectives
ABSTRACT | Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost four in five Americans with OUD do not receive any form of treatment. The gap in access to evidence-based care, including treatment with...
by Jenna Ogilvie | Sep 9, 2019 | Commentary, Perspectives
Those working on changing the course of the opioid crisis cannot afford to overlook simple solutions that could bring timely, positive results. Changing the policies that impact buprenorphine prescribing could have immediate impacts on access to...
